Management of menstrual bleeding and cycle control after hematopoietic stem cell transplant

International Journal of Gynecology and Obstetrics

Volumn 100, Issue 1, 2008, Pages 76-77

  Chang, B H ^a   Edelman, A ^b   Godder, K ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Contraceptive induced amenorrhea; HSCT; Menorrhagia; Menstrual control

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL PLUS NORELGESTROMIN; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BREAKTHROUGH BLEEDING; DRUG DOSE INCREASE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONAL CONTRACEPTION; HUMAN; MALE; MENORRHAGIA; MENSTRUAL CYCLE; MENSTRUATION; ORAL CONTRACEPTION; PRIORITY JOURNAL; VAGINA BLEEDING;

EID: 36749090104     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2007.04.036     Document Type: Article

References (2)

1. Whedon M., and Damianos F. Nursing care issues in autologous bone marrow transplantation. Oncology 7 (1993) 78-88
2. Bacigalupo A. Haemopoietic stem cell transplants: the impact of haemorrhagic complications. Blood Rev 17 Suppl 1 (2003) S6-S10